Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group. (Q54117576)
Jump to navigation
Jump to search
scientific article published in February 1994
Language | Label | Description | Also known as |
---|---|---|---|
English | Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group. |
scientific article published in February 1994 |
Statements
Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group. (English)
1 reference
W C Mertens
1 reference
E A Eisenhauer
1 reference
J Jolivet
1 reference
S Ernst
1 reference
M Moore
1 reference
A Muldal
1 reference
1 February 1994
1 reference
5
1 reference
2
1 reference
185-187
1 reference
Identifiers
1 reference